Tirzepatide
Dual GIP/GLP-1 receptor agonist compounded for individual patients. Licensed 503A pharmacy with third-party potency testing and wholesale pricing.
Get Provider Access
Talk with our clinical team about GLP-1, hormones, aesthetics, and specialty compounding. We'll verify your credentials and get you up and running.
Schedule a Call →By scheduling, you agree to our Privacy Policy.
About
Tirzepatide is a dual GIP/GLP-1 receptor agonist used in medical weight management. Originally marketed as Mounjaro® and Zepbound® by Eli Lilly, compounded tirzepatide is available from licensed 503A pharmacies for individual patients when commercially manufactured versions are unavailable or in shortage.
Promise Pharmacy compounds tirzepatide for subcutaneous injection, troches, and sublingual drops to support individual patient treatment protocols. Each preparation is made for an individual patient based on a valid prescription from a licensed provider.
Process
Apply through our partner program with your medical license and DEA registration.
Choose the tirzepatide dosage form matching your treatment protocol.
Submit individual patient prescriptions through the provider portal.
We compound and ship within 5 business days with proper cold chain packaging.
FAQ